EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Forecast, Price & News

€245.60

-3.10 (-1.25%)

(As of 05/31/2023 ET)

Compare

Today's Range: €244.50
▼
€247.40
50-Day Range: €239.60
▼
€308.60
52-Week Range: N/A

Volume: 111,561 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: €441.33

Profile Analyst Ratings Chart Competitors Headlines

About Sartorius Stedim Biotech (EPA:DIM) Stock

Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, and fluid management services; single-use and reusable hollow-fiber membrane devices, as well as presterilized assemblies for cell and gene therapy applications; and cell harvesting and various other solutions for intensified bioprocesses. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

DIM Stock News Headlines

May 16, 2023 | marketwatch.com

Aseptic Sampling System Market Research and Size Analysis 2023-2030

May 13, 2023 | marketwatch.com

2023 "Single-Use Bio-Processing System Market" Intelligence Report: Forecasting Huge Growth till 2030

June 1, 2023 | Legacy Research (Affiliate) (Ad)

“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin

$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.

May 11, 2023 | marketwatch.com

Sterile Tubing Welder Industry Size 2023, Latest Trends, Growth Drivers, Industry Analysis by Top Companies and Forecast 2030

May 10, 2023 | marketwatch.com

Bioprocess Validation Market Share and Size: 2023-2031 with Regional Overview

May 10, 2023 | marketwatch.com

2023-2031 "Sterile Homogeneous Bag Market" Development: Key Players Analysis and Innovative Growth Opportunities

May 5, 2023 | marketwatch.com

2023 Bioprocess Containers Market Size Regional Analysis by Absolute Reports | with [111 Pages] and Forecast till 2031

May 5, 2023 | marketwatch.com

Downstream Processing Market Factual Overview Research Report 2023-2030

June 1, 2023 | UNKNOWN (Ad)

Lithium Has Boomed And This American Stock Is Ready..

Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!

May 4, 2023 | marketwatch.com

Viral Clearance Market Analysis of Trends, Future Demand, and Updates from 2023 to 2030

May 3, 2023 | marketwatch.com

Miniature Bioreactors Market is Booming in Upcoming Period 2030

May 3, 2023 | marketwatch.com

2023 Aseptic Sampling System Market Size Trends Analysis by Absolute Reports | with [110 Pages] and Forecast till 2031

April 28, 2023 | marketwatch.com

Latest Insights On Sanitary Membrane Filtration Market: Trends, Growth, And Forecast By 2030

April 26, 2023 | marketwatch.com

Single Use Bioprocessing Market Growth Strategies, Size, Geography Trends and Competitive Analysis to 2030

April 25, 2023 | marketwatch.com

Depth Filtration Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030

April 21, 2023 | msn.com

BERENBERG Maintains Sartorius Stedim Biotech (EPA:DIM) Buy Recommendation

April 14, 2023 | marketwatch.com

Downstream Processing Market Size Dynamics 2023-2029

April 13, 2023 | marketwatch.com

Complete Overview of Depth Filtration Market 2023-2030

April 11, 2023 | finance.yahoo.com

Global Single-Use Bioprocessing Market Report 2023: Sector is Expected to Reach $86 Billion by 2032 at a CAGR of 15.5%

April 8, 2023 | marketwatch.com

Biotechnology Separation Systems Market Demand by 2030

April 7, 2023 | marketwatch.com

Cell Culture Media for Vaccine Market Outlook and Forecast till 2030

April 7, 2023 | marketwatch.com

Growth Analysis & Survey of High Throughput Process Development Market Size 2023-2026 | Absolute Reports

April 7, 2023 | marketwatch.com

Sterile Sampling Bags Market Insights and Forecast to 2030

April 6, 2023 | msn.com

France stocks lower at close of trade; CAC 40 down 0.39%

April 5, 2023 | marketwatch.com

Sterile Tubing Welders Market Research Report (2023) By Leading Players, Emerging Technologies, Opportunity 2029

March 31, 2023 | msn.com

France stocks higher at close of trade; CAC 40 up 0.81%

March 31, 2023 | bloomberg.com

Sartorius to Buy French Biotech Polyplus for $2.6 Billion

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: EPA
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: EPA:DIM
CUSIP: N/A
CIK: N/A
Web: www.sartorius.com
Phone: 33 4 42 84 56 00
Fax: N/A
Employees: 10,409
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: €441.33
High Stock Price Forecast: €470.00
Low Stock Price Forecast: €390.00
Forecasted Upside/Downside: +77.5%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Joachim Kreuzburg (Age 57)
Chairman & CEO
Comp: $891k

Mr. Heiko Imöhl
VP of Group Financing & Investor Relations

Ms. Petra Kirchhoff (Age 53)
Head of Corp. Communications & IR

Mr. John Gerard Mackay (Age 60)
Exec. VP of Marketing, Sales & Services for Lab Products and Services Division

Benedikt Orzelek
Head of Investor Relations

Olivier Guitard
Head of Controlling BPS

Key Competitors

View All Competitors

DIM Stock - Frequently Asked Questions

What is Sartorius Stedim Biotech's stock price forecast for 2023?: 0 equities research analysts have issued twelve-month price targets for Sartorius Stedim Biotech's stock. Their DIM share price forecasts range from €390.00 to €470.00. On average, they anticipate the company's share price to reach €441.33 in the next year. This suggests a possible upside of 77.5% from the stock's current price.
View analysts price targets for DIM or view top-rated stocks among Wall Street analysts.
How have DIM shares performed in 2023?: Sartorius Stedim Biotech's stock was trading at €302.50 at the start of the year. Since then, DIM stock has decreased by 17.8% and is now trading at €248.70.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Sartorius Stedim Biotech own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).

What is Sartorius Stedim Biotech's stock symbol?: Sartorius Stedim Biotech trades on the EPA under the ticker symbol "DIM."
What is Sartorius Stedim Biotech's stock price today?: One share of DIM stock can currently be purchased for approximately €248.70.
How many employees does Sartorius Stedim Biotech have?: The company employs 10,409 workers across the globe.
How can I contact Sartorius Stedim Biotech?: The official website for the company is www.sartorius.com. The company can be reached via phone at 33 4 42 84 56 00.

This page (EPA:DIM) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sartorius Stedim Biotech (DIM) Stock Forecast, Price & News

About Sartorius Stedim Biotech (EPA:DIM) Stock

DIM Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

DIM Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info